Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2008, Vol. 2 Issue (1) : 95-99     DOI: 10.1007/s11684-008-0017-y
Heterologous expression of signal protein 14-3-3 in and the subsequent immune response in mice
ZHENG Meijuan1, SHEN Jilong2, LUO Qingli2, XU Yuanhong3
1.Department of Laboratory Medicine, Second Affiliated Hospital of Anhui Medical University; 2.The Key Laboratory of Gene Resource Utilization for Severe Diseases, Ministry of Education (Anhui Medical University), and Anhui Key Laboratory of Zoonoses (Anhui Medical University); 3.Department of Laboratory Medicine, First Affiliated Hospital of Anhui Medical University;
Download: PDF(101 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Schistosomiasis japonica, a zoonosis caused by Schistosoma japonicum, is endemic to the Philippines and China. Several vaccine candidates have been identified and tested in different animal models, but it is still unclear which will be optimal for testing in the field. Therefore, new antigens and strategies are necessary for vaccine development against schistosomiasis japonica. The Sj14-3-3 gene was amplified and subcloned into the expression vector pPICZ?-B and transformed into P. pastoris X-33 by electroporation. Three transformants were induced with methanol. The cultural supernatant was collected and tested by SDS-PAGE and Western blotting. The protein of rSj14-3-3 was prepared and purified and BALB/c mice were immunized which was followed by a challenging infection. The immuno-protection was then evaluated. The Sj14-3-3 gene was expressed and secreted into the medium and its molecular weight was about 35000 as determined by SDS-PAGE. Western blotting showed that the protein had a high specificity against mouse-anti-Sj14-3-3 monoclonal antibody and rSj14-3-3 had a promising immune reactivity. The results of the immuno-protective experiments revealed that the worm reduction was 26.0%, 32.2%, and 36.8%, respectively. The number of eggs in liver tissue was reduced by 36.8%, 43.2%, and 46.1%, respectively. The recombinant Sj14-3-3 of eukaryotic expression in Pichia pastoris was successfully harvested. The molecular vaccine of Sj14-3-3 could partially induce resistance to the infection with S. japonicum in BALB/c mice. The recombinant protein Sj14-3-3 has promising immunological potentials for further approach to the diagnosis and development of molecular vaccine.
Issue Date: 05 March 2008
URL:     OR
1 McGarvey S T Zhou X N Willingham A L Feng Z Olveda R The epidemiology and host-parasite relationshipsof Schistosoma japonicum in definitivehostsParasitol Today 1999 15(6)214215
2 Bergquist R Al-Sherbiny M Barakat R Olds R Blueprint forschistosomiasis vaccine developmentActaTrop 2002 82(2)183192
3 Ross A G Sleigh A C Li Y Davis G M Williams G M Jiang Z Feng Z McManus D P Schistosomiasis in the People's Republic of China: prospectsand challenges for the 21st centuryClinMicrobiol Rev 2001 14(2)270295
4 WHO. Global schistosomiasis atlas 2005
5 Ross A G Bartley P B Sleigh A C Olds G R Li Y Williams G M McManus D P SchistosomiasisN Engl J Med 2002 346(16)12121220
6 McManus D P Bartley P B A vaccine against Asian schistosomiasisParasitol Int 2004 53(2)163173
7 Zhang D M Pan W Q Qian L Duke M Shen L H McManus D P Investigationof recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy inmiceParasite Immunol 2006 28(3)7784
8 MacGonigle S Beall M J Feeney E L Pearce E J Conserved rolefor 14-3-3epsilon downsteam of type I TGFbeta receptorsFEBS Lett 2001 490(1–2)6569
9 MacGonigle S Feeney E L Beall M J Pearce E J SIP, a novelSH3 domain-containing protein, interacts with Schistosoma mansoni receptor kinase 1Mol Biochem Parasitol 2001 114(1)119123
10 Schechtman D Tarrab-Hazdai R Arnon R The 14-3-3 protein as a vaccine candidate against schistosomiasisParasite Immunol 2001 23(4)213217
11 Zhang Y Taylor M G McCrossan M V Bickle Q D Molecular cloningand characterization of a novel Schistosomajaponicum “irradiatedvaccine-specific” antigen, Sj14-3-3Mol Biochem Parasitol 1999 103(1)2534
12 Cereghino J L Cregg J M Heterologous protein expressionin the methylotrophic yeast Pichia pastorisFEMS Microbiol Rev 2000 24(1)4566
13 Jana S Deb J K Strategies for efficient productionof heterologous proteins in Escherichia coliAppl Microbiol Biotechnol 2005 67(3)289298
14 Tanner W Lehle L Protein glycosylation in yeastBiochim Biophys Acta 1987 906(1)8189
15 Borgheresi R A Palma M S Ducancel F Camargo A C Carmona E Expression and processing of recombinantsarafotoxins precursor in Pichia pastorisToxicon 2001 39(8)12111218
16 Macauley-Patrick S Fazenda M L McNeil B Harvey L M Heterologousprotein production using the Pichia pastoris expression systemYeast 2005 22(4)249270
17 Lin Cereghino G P Sunga A J Lin Cereghino J Cregg J M Expressionof foreign genes in the yeast Pichia pastorisGenet Eng (N Y) 2001 23157169
18 Yu P Neamati N Tarasov S He Q Sheikh M S Wang Y X Codon-optimizedcloning, expression and characterization of the C-terminal regionof human apoptotic protein GADD34 in Escherichia coliCell Cycle 2004 3(1)7579
19 Song H Zhou L Fang W Li Y Wang X Fang H Li X Wu M Qiu B High-level expressionof codon optimized foot-and-mouth disease virus complex epitopes andcholera toxin B subunit chimera in Hansenula polymorphaBiochem Biophys Res Commun 2004 315(1)235239
No related articles found!
Full text